Products for Research Use Only
RegisterLogin

ARV-771

CAT: 0804-HY-100972-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-100972-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ARV-771 is a potent BET PROTAC based on E3 ligase von Hippel-Lindau with Kds of 34 nM, 4.7 nM, 8.3 nM, 7.6 nM, 9.6 nM, and 7.6 nM for BRD2 (1), BRD2 (2), BRD3 (1), BRD3 (2), BRD4 (1), and BRD4 (2), respectively[1].
CAS Number
1949837-12-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ARV-771.html
Purity
99.87
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CC(C(C(C1=CC=C(Cl)C=C1)=N[C@@H](CC(NCCOCCCOCC(N[C@@H](C(C)(C)C)C(N(C[C@H](O)C2)[C@@H]2C(N[C@H](C3=CC=C(C(SC=N4)=C4C)C=C3)C)=O)=O)=O)=O)C5=NN=C(C)N65)=C6S7)=C7C
Molecular Formula
C49H60ClN9O7S2
Molecular Weight
986.64
Precautions
H302, H315, H319, H335
References & Citations
[1]Raina K, et al. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016 Jun 28;113 (26) :7124-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD2; BRD3; BRD4

Related Products

CatalogName
HY-156965-01BAY-771
HY-145264-01OARV-771
HY-158105-01ARV-393
HY-16954-01ARV-825
HY-W999697CRBN ligand-771
HY-153718KI-ARv-03
HY-105506EXP-7711
HY-107094-01MT-7716 hydrochloride
HY-107094AMT-7716 (free base)
HY-RS01049ARV1 Human Pre-designed siRNA Set A

Alternative Products

CatalogName
BA4656-50ARV-771
7256/5ARV 771

Popular Products